Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab-Reference-Cited by-同舟云学术

Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab

Published:2018-03-01 Issue:5 Volume:178 Page:1064-1071
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Warren R.B.¹,Brnabic A.²,Saure D.²,Langley R.G.³,See K.²,Wu J.J.⁴,Schacht A.²,Mallbris L.²,Nast A.⁵

Affiliation:

1. Dermatology Centre; Salford Royal NHS Foundation Trust; The University of Manchester; Manchester Academic Health Science Centre; NIHR Manchester Biomedical Research Centre; Manchester U.K.

2. Eli Lilly and Company; Lilly Corporate Center; Indianapolis IN U.S.A.

3. Division of Clinical Dermatology and Cutaneous Science; Dalhousie University; Halifax NS Canada

4. Department of Dermatology; Kaiser Permanente Los Angeles Medical Center; Los Angeles CA U.S.A.

5. Division of Evidence-Based Medicine; Department of Dermatology, Venereology and Allergology; Charité Universitätsmedizin Berlin; Berlin Germany

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.16140/fullpdf

Reference24 articles.

1. A new era in the management of psoriasis? The biologics: facts and controversies;Ferrandiz;Clin Dermatol,2010

2. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials;Griffiths;Lancet,2015

3. Secukinumab in plaque psoriasis-results of two phase 3 trials;Langley;N Engl J Med,2014

4. Phase 3 trials of ixekizumab in moderate-to-severe plaque psoriasis;Gordon;N Engl J Med,2016

5. Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE);Blauvelt;Br J Dermatol,2015

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the VOYAGE 1 Clinical Trial;Dermatology and Therapy;2024-08-17

2. Frequency of use and annual costs of biological therapy for psoriasis in Colombia in 2019;International Journal of Dermatology;2024-07-19

3. Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis;Dermatology and Therapy;2024-04

4. Structural Basis for p19 Targeting by Anti–IL-23 Biologics: Correlations with Short- and Long-Term Efficacy in Psoriasis;JID Innovations;2024-03

5. A Comparison of Relative-Efficacy Estimate(S) Derived From Both Matching-Adjusted Indirect Comparisons and Standard Anchored Indirect Treatment Comparisons: A Review of Matching-Adjusted Indirect Comparisons;Value in Health;2023-11